These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 10469940)

  • 41. [Informal coercion to enhance treatment adherence among psychiatric patients].
    Jäger M; Rössler W
    Neuropsychiatr; 2009; 23(4):206-15. PubMed ID: 19909692
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Improving patient outcomes in schizophrenia: achieving remission, preventing relapse, and measuring success.
    Kane JM
    J Clin Psychiatry; 2013 Sep; 74(9):e18. PubMed ID: 24107769
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Attitudes Toward Medications and the Relationship to Outcomes in Patients with Schizophrenia.
    Campbell AH; Scalo JF; Crismon ML; Barner JC; Argo TR; Lawson KA; Miller A
    Clin Schizophr Relat Psychoses; 2018; 12(1):12-22. PubMed ID: 26218237
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Attitudes toward antipsychotic medication, insight and psychopathology in outpatients with schizophrenia.
    Vassileva IV; Milanova VK
    Folia Med (Plovdiv); 2012; 54(4):62-8. PubMed ID: 23441471
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Medication adherence and long-term functional outcomes in the treatment of schizophrenia in usual care.
    Ascher-Svanum H; Faries DE; Zhu B; Ernst FR; Swartz MS; Swanson JW
    J Clin Psychiatry; 2006 Mar; 67(3):453-60. PubMed ID: 16649833
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Insight into illness and attitudes toward medications among inpatients with schizophrenia.
    Sajatovic M; Rosch DS; Sivec HJ; Sultana D; Smith DA; Alamir S; Buckley P; Bingham CR
    Psychiatr Serv; 2002 Oct; 53(10):1319-21. PubMed ID: 12364685
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Attitudes toward antipsychotics among outpatient clinic attendees with schizophrenia.
    Hofer A; Kemmler G; Eder U; Honeder M; Hummer M; Fleischhacker WW
    J Clin Psychiatry; 2002 Jan; 63(1):49-53. PubMed ID: 11838626
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Adherence to therapy in multiple sclerosis and schizophrenia].
    Bussfeld P; Czekalla J
    Fortschr Neurol Psychiatr; 2010 Mar; 78(3):139-46. PubMed ID: 20213580
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Compliance in schizophrenia: psychopathology, side effects, and patients' attitudes toward the illness and medication.
    Rettenbacher MA; Hofer A; Eder U; Hummer M; Kemmler G; Weiss EM; Fleischhacker WW
    J Clin Psychiatry; 2004 Sep; 65(9):1211-8. PubMed ID: 15367047
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Predictors of medication non-adherence among a Moroccan sample of patients with schizophrenia: A cross sectional study].
    El Ammouri A; Kisra H
    Encephale; 2017 Dec; 43(6):522-527. PubMed ID: 27663045
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Continuous versus targeted medication in schizophrenic outpatients: outcome results.
    Carpenter WT; Hanlon TE; Heinrichs DW; Summerfelt AT; Kirkpatrick B; Levine J; Buchanan RW
    Am J Psychiatry; 1990 Sep; 147(9):1138-48. PubMed ID: 1974743
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Compliance therapy: a randomised controlled trial in schizophrenia.
    O'Donnell C; Donohoe G; Sharkey L; Owens N; Migone M; Harries R; Kinsella A; Larkin C; O'Callaghan E
    BMJ; 2003 Oct; 327(7419):834. PubMed ID: 14551096
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Recent psychostimulant use in hospitalized schizophrenics.
    Richard ML; Liskow BI; Perry PJ
    J Clin Psychiatry; 1985 Mar; 46(3):79-83. PubMed ID: 2857708
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Drug default among schizophrenic patients.
    Nelson AA; Gold BH; Hutchinson RA; Benezra E
    Am J Hosp Pharm; 1975 Dec; 32(12):1237-42. PubMed ID: 1108645
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evaluation of the factors interfering with drug treatment compliance among Brazilian patients with schizophrenia.
    Rosa MA; Marcolin MA; Elkis H
    Braz J Psychiatry; 2005 Sep; 27(3):178-84. PubMed ID: 16224604
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Insight and adherence to medication in chronic schizophrenics.
    Lin IF; Spiga R; Fortsch W
    J Clin Psychiatry; 1979 Oct; 40(10):430-2. PubMed ID: 489521
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Predictors of poor adherence to medication among patients with first-episode schizophrenia-spectrum disorder.
    Quach PL; Mors O; Christensen TØ; Krarup G; Jørgensen P; Bertelsen M; Jeppesen P; Petersen L; Thorup A; Nordentoft M
    Early Interv Psychiatry; 2009 Feb; 3(1):66-74. PubMed ID: 21352177
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Impact of present and past antipsychotic side effects on attitude toward typical antipsychotic treatment and adherence.
    Lambert M; Conus P; Eide P; Mass R; Karow A; Moritz S; Golks D; Naber D
    Eur Psychiatry; 2004 Nov; 19(7):415-22. PubMed ID: 15504648
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Insight in schizophrenia. Its relationship to acute psychopathology.
    McEvoy JP; Apperson LJ; Appelbaum PS; Ortlip P; Brecosky J; Hammill K; Geller JL; Roth L
    J Nerv Ment Dis; 1989 Jan; 177(1):43-7. PubMed ID: 2562850
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A prospective study of factors influencing adherence to a continuous neuroleptic treatment program in schizophrenia patients during 2 years.
    Linden M; Godemann F; Gaebel W; Köpke W; Müller P; Müller-Spahn F; Pietzcker A; Tegeler J
    Schizophr Bull; 2001; 27(4):585-96. PubMed ID: 11824485
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.